Advertisement

Topics

Prescribed Reading: More portfolios reshuffled

05:00 EDT 4 Aug 2017 | BioPharmaDive

Restructuring continued throughout the industry, as more companies attempt to cut costs or excess programs. Meanwhile, the FDA kept up its rapid pace of drug approvals.

Original Article: Prescribed Reading: More portfolios reshuffled

NEXT ARTICLE

More From BioPortfolio on "Prescribed Reading: More portfolios reshuffled"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...